Back to Search Start Over

SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron.

Authors :
Mazzoni, Alessio
Vanni, Anna
Spinicci, Michele
Capone, Manuela
Lamacchia, Giulia
Salvati, Lorenzo
Coppi, Marco
Antonelli, Alberto
Carnasciali, Alberto
Farahvachi, Parham
Giovacchini, Nicla
Aiezza, Noemi
Malentacchi, Francesca
Zammarchi, Lorenzo
Liotta, Francesco
Rossolini, Gian Maria
Bartoloni, Alessandro
Cosmi, Lorenzo
Maggi, Laura
Annunziato, Francesco
Source :
Frontiers in Immunology; 1/26/2022, Vol. 13, p1-8, 8p
Publication Year :
2022

Abstract

Although accumulating data have investigated the effect of SARS-CoV-2 mutations on antibody neutralizing activity, less is known about T cell immunity. In this work, we found that the ancestral (Wuhan strain) Spike protein can efficaciously reactivate CD4+ T cell memory in subjects with previous Alpha variant infection. This finding has practical implications, as in many countries only one vaccine dose is currently administered to individuals with previous COVID-19, independently of which SARS-CoV-2 variant was responsible of the infection. We also found that only a minority of Spike-specific CD4+ T cells targets regions mutated in Alpha, Beta and Delta variants, both after natural infection and vaccination. Finally, we found that the vast majority of Spike-specific CD4+ T cell memory response induced by natural infection or mRNA vaccination is conserved also against Omicron variant. This is of importance, as this newly emerged strain is responsible for a sudden rise in COVID-19 cases worldwide due to its increased transmissibility and ability to evade antibody neutralization. Collectively, these observations suggest that most of the memory CD4+ T cell response is conserved against SARS-CoV-2 variants of concern, providing an efficacious line of defense that can protect from the development of severe forms of COVID-19. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16643224
Volume :
13
Database :
Complementary Index
Journal :
Frontiers in Immunology
Publication Type :
Academic Journal
Accession number :
154895581
Full Text :
https://doi.org/10.3389/fimmu.2022.801431